Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis

Combining neoadjuvant chemotherapy with PD-1/PD-L1 inhibitors for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis

BackgroundImmune checkpoint inhibitors (ICIs) have shown promising prospects in locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma (GC/GEJC) immunotherapy, but their efficacy in neoadjuvant settings remains unclear. This study aimed to assess the efficacy and safety of...

Full description

Bibliographic Details
Main Authors: Zhen Yuan, Hao Cui, Shuyuan Wang, Wenquan Liang, Bo Cao, Liqiang Song, Guibin Liu, Jun Huang, Lin Chen, Bo Wei
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
gastric adenocarcinoma
gastroesophageal junction adenocarcinoma
PD-1/PD-L1 inhibitors
immune checkpoint inhibitors
neoadjuvant immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1103320/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1103320/full

Similar Items